Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy

The Journal of Pathology: Clinical Research · Published 2026-08-02 · DOI 10.1002/2056-4538.70111

Free full text

Authors (5)

Mohamed A Yakoub, Purvil Sukhadia, Carla Saoud, Meera Hameed, Cristina R Antonescu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yakoub, M., Sukhadia, P., Saoud, C., et al. (2026). Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70111

Related articles

• Development of a decision tree diagram for classifying study designs in tumour pathology research: a multidisciplinary approach · The Journal of Pathology: Clinical Research · 2025 · Same journal
• The diagnostic landscape of bone and soft tissue sarcoma: the pan‐sarcoma era and AI ‐driven classification · The Journal of Pathology: Clinical Research · 2025 · Same journal
• Implementing Immunoscore in colorectal cancer: lessons from cohort studies, limitations and barriers to adoption · The Journal of Pathology: Clinical Research · 2025 · Same journal
• Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988–2016 · The Journal of Pathology: Clinical Research · 2025 · Same journal
• Reduced folate receptor alpha ( FOLR1 ) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy · The Journal of Pathology: Clinical Research · 2026 · Same journal
• Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancer · The Journal of Pathology: Clinical Research · 2026 · Same journal
• AI for pathologists: a universal lymph node metastasis detection app that enhances efficiency while preserving diagnostic accuracy · The Journal of Pathology: Clinical Research · 2026 · Same journal
• Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma · The Journal of Pathology: Clinical Research · 2026 · Same journal
• Context is key: how diagnostic and prognostic markers are reshaping gynecologic pathology · The Journal of Pathology: Clinical Research · 2025 · Same journal
• Oestrogen receptor phosphorylation profiles and in silico PAM50 subtyping reflect sexual dimorphism in breast cancer · The Journal of Pathology: Clinical Research · 2026 · Same journal